For those patients who do not have an HLA-matched donor, HSC-gene therapy (HSC-GT) has been successfully developed for several PIDs including ADA-SCID, SCID due to γ-chain deficiency, WAS and CGD24, 25. Here, ADA is linked to severe combined immunodeficiency.